Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

CARB-X option funding supports Clarametyx's development of anti-biofilm therapy CMTX-101

April 5, 2022

Aligos selects broad-spectrum coronavirus protease inhibitor ALG-097558 for advancement

April 5, 2022

Tollovir and Tollovid show 3CL protease inhibition in vitro against Omicron SARS-CoV-2 variants

April 5, 2022

Inhaled bispecific single-domain antibody neutralizes multiple SARS-CoV-2 variants

April 5, 2022

Blockade of PTGDR protects mice from severe SARS-CoV-2 infection

April 4, 2022

New antifungals synthesized at Kyung Hee University

March 30, 2022

Novartis details discovery, preclinical data of novel antimalarial compound INE-963

March 28, 2022

New antibacterials identified at Roche

March 28, 2022

Medshine Discovery presents new antifungal compounds

March 25, 2022

Roche patents compounds for Gram-negative bacterial infections

March 25, 2022

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...